ERK1/2-targeted Cancer therapies: Recent advances, potential drug resistance, and applicability analysis of emerging technologies

Bioorganic Chemistry 2026

View at publisher

Authors: Xinyue Mao, Jishun Quan, Tianyu Niu, Zhuo Zhang, Jiawei Zhao, Hu He, Qin Yin

DOI: 10.1016/j.bioorg.2026.109775

Cited by: 3

References: 83

Fields of Study & Subjects

Melanoma and MAPK Pathways Fibroblast Growth Factor Research Chromatin Remodeling and Cancer

References 83